The Rx Research Corner is a blog written by the Research Team at PCMA. This blog will take a closer look at complex data and new research findings. Topics cover the PBM and prescription drug space and range from pricing, to policies, and to patient issues such as access and equity.
PBM Technology and Expertise Improves Patient Health Outcomes
Pharmacy Benefit Managers reduce prescription drug costs for patients and use innovative technology to help patients get their prescriptions and lead healthier lives.
Orphan Drugs Sound Small but Can Lead to Big Drug Spending
High spending on prescription drugs with both orphan and non-orphan indications suggest potential misuse of Orphan Drug Act designations.
There are More Independent Pharmacies, Just Look at Real, Accurate Data
Using a gold-standard pharmacy dataset from the National Council for Prescription Drug Programs (NCPDP) and a transparent methodology, PCMA produces credible research with a clear conclusion: there are more independent pharmacies now than any time over the last decade.
Mandating Pharmacy Reimbursement Will Increase Prescription Drug Spending
Paying pharmacies more for dispensing medications will raise prescription drug costs without improving value.
Biosimilars Versus Biologics – How About Both?
Biosimilars play an important role in lowering net costs.
The Upside of More Drugs: How Competition Among Brand-Name Drugs Works for Patients
PBMs leverage competition between drugs to create savings for patients.